Continuous drug delivery(CDD)is used in moderately advanced and late-stage Parkinson’s disease(PD)to control motor and non-motor fluctuations(‘OFF’periods).Transdermal rotigotine is indicated for early fluctuations...
This work was supported by the National Natural Science Foundation of China,Nos.81571225 and 81971192(both to AMX).
Dysfunctional autophagy often occurs during the development of neurodegenerative diseases,such as Parkinson’s disease,Huntington’s disease,and Alzheimer’s disease.The purinergic P2X4 receptor is an ATP-gated ion ch...
The Lundbeck Foundation for the financial support(R108-A10772)
Parkinson's disease(PD) is a chronic debilitating disease affecting approximately 1% of the population over the age of 60. The severity of PD is correlated to the degree of dopaminergic neuronal loss. Apomorphine has ...
supported by grants from the PRODEP,No.CA-BUAP-120;the CONACYT grant,No.252808(to GF);MINECO/FEDER grant,No.BFU2012-38208;the Junta de Andalucía,No.P11-CVI-7290(to ARM)
Apomorphine is a non-specific dopamine receptor agonist that has been used in the treatment of some diseases and mental disorders. Its use has particularly well documented in Parkinson's disease(PD). The dopaminerg...
supported by the National Natural Science Foundation of China,No.81571250
To prevent and treat Parkinson's disease in its early stages,it is essential to be able to detect the degree of early dopaminergic neuron degeneration.Dopamine transporters(DAT) in the striatum regulate synaptic do...
Introduction: Continuous apomorphine infusion (CAI) is effective in improving complications in advanced Parkinson’s disease (APD). The effectiveness and tolerance of CAI in patients with APD with varying degrees of f...
financial support of the Institute for the promotion of Innovation by Science and Technology in Flanders(IWT)(IWT420);National Fund for Scientific Research(FWO-Vlaanderen)(G.0071.05)and of the Research Council of the Vrije Universiteit Brussel;research grant from the IWT(IWT420).
The dopamine D1-D2 receptor agonist, R-apomorphine, has been shown to be neuroprotective in different models of Parkinson’s disease. Different mechanisms of action for this effect have been proposed, but not verified...
Supported by A PhD studentship from Merck Research Laboratories (to Percie du Sert N)
AIM: To characterize the gastric myoelectric activity (GMA) and intra-abdominal pressure changes induced by emetic stimuli (apomorphine and cisplatin) in the ferret. METHODS: GMA and intra-abdominal pressure wer...
Project supported by the National Basic Research Program 973 from Ministry of Science and Technology in China(№2003CB515401)
Aim: (-)Stepholidine (SPD) is an active ingredient of the Chinese herb Stephania intermedia, which binds to the dopamine D1 and D2 like receptors. Biochemical, electrophysiological and behavioural experiments hav...